Android app Apple app link

H.C. Wainwright Lowers ADC Therapeutics (ADCT) PT to $7 Following $60M Private Placement

By Yahoo! Finance   |   1 month ago
H.C. Wainwright Lowers ADC Therapeutics (ADCT) PT to $7 Following $60M Private Placement

ADC Therapeutics (NYSE:ADCT) is a promising long-term penny stock with significant potential. H.C. Wainwright analyst Robert Burns adjusted the price target to $7 due to private placement financing.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.